Regulating myeloperoxidase by sinomenine to attenuate macrophage inflammation in respiratory syncytial virus infection
Letters in Drug Design & Discovery · 2026-11 · 100642
DOI: 10.1016/j.lddd.2026.100642 ↗Kurz gefasst
Fachartikel in der Zeitschrift Letters in Drug Design & Discovery, 2026-11. Verfasst von Na Guo und 7 weiteren Autor:innen. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hebei Province Health Commission.
Abstract (Originalsprache)
Background
Respiratory syncytial virus (RSV) is an RNA virus that causes acute lower respiratory tract infection. Sinomenine alleviates RSV-induced airway inflammation, but its molecular mechanism remains unclear.
Methods
The gene expression omnibus (GEO) database was used to download datasets related to RSV-induced airway inflammation. Weighted gene co-expression network analysis (WGCNA) and differential analysis were performed to identify key targets. Gene ontology (GO) and kyoto encyclopedia of genes and genomes (KEGG) enrichment analyses were performed using the search tool for the retrieval of interacting genes (STRING) platform. The comparative toxicogenomics database (CTD), SwissTarget, Super-PRED, and GeneCards were used to obtain sinomenine and macrophage target information. Random forest (RF) was applied to screen core targets. Single-sample gene set enrichment analysis (ssGSEA) and Spearman correlation analysis were used to identify differential immune cell subsets and their correlations with targets. Universal protein resource (UniProt) and protein data bank (PDB) databases were used to download small molecule compounds and protein structures, and Autodock Vina 1.1.2 was used for molecular docking. Cell viability was assessed using the CCK-8 assay. Real-time quantitative polymerase chain reaction (RT-qPCR) and western blot were used to detect mRNA and protein expression. Enzyme-linked immunosorbent assay (ELISA) kits were used to measure myeloperoxidase (MPO) activity and the levels of inflammatory cytokines. The binding between intracellular proteins and small-molecule compounds was evaluated using the cellular thermal shift assay (CETSA). A reactive oxygen species (ROS) detection kit was used to measure ROS levels.
Results
WGCNA and differential expression analyses identified 118 key genes associated with RSV-induced airway inflammation. KEGG and GO enrichment analyses showed that these genes were mainly involved in cell cycle regulation, immune responses, and the secretion of inflammatory mediators. Intersection analysis with sinomenine- and macrophage-related targets identified five core targets, among which MPO was significantly associated with macrophage infiltration. Random forest (RF) analysis ranked cyclin A2 (CCNA2), MPO, aurora kinase B (AURKB), DNA topoisomerase II alpha (TOP2A), and checkpoint kinase 1 (CHEK1) as the most important core targets. Molecular docking predicted potential interactions between sinomenine and MPO, and experimental assays demonstrated that sinomenine significantly downregulated MPO expression and enzymatic activity in RSV-infected macrophages ( P < 0.001). Both MPO knockdown and sinomenine treatment modulated cytokine expression, decreasing interleukin-1 beta (IL-1β) ( P < 0.01), interleukin-6 (IL-6) ( P < 0.001), and tumor necrosis factor-alpha (TNF-α) ( P < 0.001), while increasing interleukin-10 (IL-10) ( P < 0.001). These interventions also reversed RSV-induced M1 polarization, as evidenced by decreased CD86 expression and increased CD206 expression ( P < 0.001), as well as reduced ROS production ( P < 0.001). Under MPO knockdown conditions, sinomenine further regulated macrophage phenotype and ROS levels, suggesting that its anti-inflammatory and immunomodulatory effects may be partially mediated by MPO, though MPO-independent pathways might also be involved.
Conclusion
Sinomenine may exert its anti-inflammatory effects in RSV-induced airway inflammation by regulating MPO expression and activity and attenuating macrophage inflammatory responses, suggesting a possible involvement of MPO in its mechanism of action.
Förderung
- Hebei Province Health Commission
Zitieren
APA
Guo, N., Meng, B., Jia, H., Wang, L., Wang, X., Zhao, Z., Huo, X., & Chen, L. (2026). Regulating myeloperoxidase by sinomenine to attenuate macrophage inflammation in respiratory syncytial virus infection. Letters in Drug Design & Discovery, 100642. https://doi.org/10.1016/j.lddd.2026.100642
Vancouver
Guo N, Meng B, Jia H, Wang L, Wang X, Zhao Z, et al. Regulating myeloperoxidase by sinomenine to attenuate macrophage inflammation in respiratory syncytial virus infection. Letters in Drug Design & Discovery. 2026:100642. doi:10.1016/j.lddd.2026.100642
BibTeX
@article{Guo2026,
author = {Guo, Na and Meng, Bing and Jia, Hao and Wang, Lixian and Wang, Xu and Zhao, Zhihong and Huo, Xiaosai and Chen, Limi},
title = {Regulating myeloperoxidase by sinomenine to attenuate macrophage inflammation in respiratory syncytial virus infection},
journal = {Letters in Drug Design & Discovery},
year = {2026},
pages = {100642},
doi = {10.1016/j.lddd.2026.100642}
}
EUVIMED